1. PRLog Home
  2. Business Index
  3. Pressroom Index
  4. Press Releases Home
  1. About
  2. Press Room
  3. Contact
Filter By Industry
Filter By Tag

Press Room

The PRactice Press releases

1 - 10 of 13 Press Releases

Feb 13, 2014
‘Operation Black Dot’ aims for 100 percent voter registration among students of Mumbai University

Dec 07, 2012
Used for the treatment of locally advanced or metastatic, hormone-dependent prostate cancer

Nov 19, 2012
Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched Sildenafil Tablets (20 mg) a bioequivalent generic version of REVATIO® (Sildenafil) Tablets in the US market on November16, 2012.

Oct 22, 2012
Dr. Reddy’s Laboratories Limited (NYSE: RDY) (“Dr. Reddy’s”), together with its subsidiaries, announces the intended public offer to acquire the issued and outstanding shares of OctoPlus N.V.

Oct 09, 2012
The Custom Pharmaceutical Services (CPS) business of Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) today announced expansion in the areas of activated mPEG manufacturing and in the development and manufacture of NCE (New Chemical Entities) APIs

Sep 27, 2012
Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched Montelukast Sodium Oral Granules, a bioequivalent generic version of Singulair® (montelukast sodium) oral granules in the US market.

Jul 19, 2012
Dr. Reddy’s Q1 FY13 Financial Results Q1 FY13 Revenues at `25.4 billion, YoY growth of 28% Q1 FY13 PAT at `3.4 billion, YoY growth of 28%

Jul 18, 2012
Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched ATORVASTATIN CALCIUM TABLETS 10 mg, 20 mg, 40 mg and 80 mg, a bioequivalent generic version of LIPITOR® (atorvastatin calcium) tablets in the US market on July 17, 2012

Jul 02, 2012
Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched Ibandronate Sodium tablets (150 mg), a bioequivalent generic version of BONIVA ® tablets in the US market on June 29, 2012

Jun 07, 2012
Dr. Reddy’s Laboratories announced today that it has launched Ropinirole Hydrochloride XR (Extended-Release) tablets (2 mg, 4 mg, 6 mg, 8mg, and 12 mg)


Page:

RSS Feed for The PRactice Press Releases